Scott Dworkin says the CDC's Ebola contract with XpresTest was 'NOT COMPETED' and has since grown
Scott DworkinPolitical commentator and writer of The Dworkin Report, in his Substack newsletter
In his November 13 newsletter, Dworkin says ProPublica's report is the kind of thing Congress should examine. He disputes the XWELL chief executive's account of competitive bidding, citing the CDC contract record, and says a November 6 addition of $16.7 million brings the company's awards to $55.5 million.
Responding to
XpresTest won its CDC Ebola entry screening contract and its State Department outbreak response award through competitive bidding.
“ProPublica showed this week exactly the type of thing Congress should be looking at. In February, an investment fund linked to Trump’s sons put about $30 million into a company called XWELL. Months later, the regime handed XWELL’s testing business nearly $40 million in contracts to screen for Ebola and other diseases. A spokesperson for Trump’s sons told ProPublica they are passive investors who had no involvement in the contracts. XWELL’s CEO told ProPublica the company won through competitive bidding. So I pulled the CDC contract’s records myself. They say “NOT COMPETED.” Only one offer came in. Then on November 6, the CDC chose to put $16.7 million more into the same contract. That money isn’t in the figure reported this week. It brings the total to $55.5 million.”
Original text
Original text
Reporting

Where this statement fits
XpresTest won more than $55 million in Ebola awards months after a fund tied to Trump's sons invested in its parent; the sons say they had no role
On November 9, 2026, ProPublica reported that XpresTest, the biosurveillance subsidiary of XWELL Inc., received an $18.8 million CDC contract to screen travelers for Ebola at U.S. airports and a $20 million State Department award for outbreak response in the Democratic Republic of Congo. Both came months after American Ventures, a fund launched by Dominari Holdings, invested about $30 million in XWELL. Dominari hired Donald Trump Jr. and Eric Trump as advisers and gave them a stake of more than 10%, according to ProPublica. XWELL's chief executive, Ezra Ernst, told ProPublica that XpresTest won both awards in competitive bidding. The federal award record for the CDC contract lists it as not competed, with one offer received, under the urgency exception in FAR 6.302-2. A modification signed November 6 exercises an option on that contract and brings its total obligations to $35.5 million, according to the federal procurement record. The State Department says its award was competitive. A spokesperson for the Trump sons says they are passive minority investors in the fund and had no involvement in the contracts.
Source and context
Original text
About this source
An edition of Dworkin's newsletter, The Dworkin Report, on congressional Democrats' oversight plans. One section discusses ProPublica's XWELL report and the federal procurement record for the CDC's Ebola screening contract with XpresTest.
Original text
About this source
The federal procurement record for the CDC's Ebola entry screening contract with XpresTest lists the original award of July 6, 2026 and three modifications. Modification P00003, signed November 6, 2026, exercises an option and obligates $16,720,916, bringing total obligations to $35,536,326.68. Each entry lists the contract as not competed under the urgency exception, with one offer received.
Reporting
About this source
ProPublica reports that XpresTest, a subsidiary of XWELL, received an $18.8 million CDC contract for Ebola entry screening at U.S. airports and a $20 million State Department award for outbreak response in the Democratic Republic of Congo, months after American Ventures, a fund launched by Dominari Holdings, invested about $30 million in XWELL. It includes responses from the State Department, a spokesperson for Donald Trump Jr. and Eric Trump, Dominari's chief executive and XWELL's chief executive.
Archived copy (opens in a new tab)Before the quotation
The passage follows Dworkin's account of warnings that Trump administration lawyers sent that week to Rep. Robert Garcia, the top Democrat on the House Oversight Committee, and Sen. Richard Blumenthal over their investigations.
After the quotation
The federal procurement record lists the CDC contract as not competed under the urgency exception, with one offer received, and shows a November 6 option exercise of $16,720,916 that brings its total obligations to $35,536,326.68. ProPublica reports that the State Department award was $20 million and that the State Department says it was made through a competitive process.
How this statement is classified
The label describes this statement's response within the context above.
Why this label?
Dworkin presents the awards as a matter for congressional oversight and uses the contract record to dispute the company's account that it won them through competitive bidding, so we labeled it Condemned.
- Recorded on
- Published here
- People and groups discussed
- XWELL, Inc., Centers for Disease Control and Prevention
More from this case
Read the full caseLevin tells Eric Trump that if he has receipts contradicting ProPublica, 'now would be a good time to show them'
“If he has receipts that contradict ProPublica’s reporting, now would be a good time to show them.”Read statement
Eric Trump calls the XpresTest report 'an absolutely fake story' and says he will sue ProPublica
“This is an absolutely fake story as usual—one of about 20 I have seen targeting anyone and everything Trump this week. A legal letter and my intent to sue ProPublica have already been issued (see below). Two minutes of research shows that this company’s relationship with the CDC occurred in 2021, under the Biden Administration. I have nothing to do with this company other than being a passive investor in an entity that has a minority interest. I have never spoken to them; I don’t know anybody from their management team, what they do, or who they are. Nothing. This is slander, and I will hold anyone— which will start with ProPublica—who suggests otherwise liable.”Read statement
Rep. Mike Levin calls the XpresTest awards 'all totally corrupt' and says Americans deserve answers under oath
“Their fund buys in, and federal money follows. Taxpayers foot the bill, and with Ebola, our safety is on the line too. This is all totally corrupt. Americans deserve answers under oath, and our conflict of interest and procurement laws must be enforced.”Read statement
Share or embed this statement
The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.
Cite this record
- Publisher
- The Dispute Index
- Title
- Scott Dworkin says the CDC's Ebola contract with XpresTest was 'NOT COMPETED' and has since grown
- First published
- Last updated
- Permalink
- https://disputeindex.com/events/9091-in-his-november-13-newsletter-dworkin-says-propublica
Last updated marks the most recent saved version of this published statement.
The Dispute Index. "Scott Dworkin says the CDC's Ebola contract with XpresTest was 'NOT COMPETED' and has since grown". First published: 2026-11-15. Last updated: 2026-11-15. https://disputeindex.com/events/9091-in-his-november-13-newsletter-dworkin-says-propublica